Global Diagnostics and Therapeutics for HIV Markets, 2017-2023 - ResearchAndMarkets.com
The "Diagnostics and Therapeutics for HIV: Global Markets" report has been added to ResearchAndMarkets.com's offering.
This report organizes information from diverse sources into sections, including an overview, industry structure, diagnostic test type, treatment by drug categories, leading drug profiles and historic drug sales, regulations, reimbursements and patents.
The scope of this report includes an overview of the global market scenario for diagnosis and treatments of HIV, with base year data from 2017, estimations for 2018 and forecasts for 2023 using projections of CAGR during the forecast period.
Market data in terms of value is provided at global, regional and country levels for treatments by drug categories. Market data for HIV diagnostics is provided for regional levels, with details on test types. Estimated values are based on companies' total revenues.
The report forecasts the global market for HIV therapeutics by drug class and discusses market data for nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), single tablet regimen fixed-dose combination (STR FDC), HIV integrase stand transfer inhibitors (INSTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). The enzyme inhibitor drug class has been excluded when calculating the global HIV therapeutics market, as there are no late-stage pipeline molecules.
Diagnostic tests such as antigen- and antibody-based tests, CD4 tests and viral load tests are detailed with current and forecasted market data. Antigen- and antibody-based tests cover enzyme-linked immunosorbent assay (ELISA) tests, enzyme immunoassay (EIA) tests, rapid tests and NAT tests; CD4 tests include tests conducted to monitor the CD4 load; and viral load tests include all PCR-based tests.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary And Highlights
Chapter 3 Overview
Chapter 4 Global Industry Trends
Chapter 5 Global HIV Therapeutics Market
Chapter 6 HIV Therapeutics Market By ARV Drug Categories
Chapter 7 Leading Drugs In The HIV Therapeutics Market
Chapter 8 HIV Diagnostics Market
Chapter 9 Pipeline Analysis
Chapter 10 Regulatory And Reimbursement Structure
Chapter 11 Competitive Landscape And Key Developments
Chapter 12 Company Profiles
- Abbott Laboratories
- Abbvie Inc.
- Agilent Technologies Inc.
- Aurobindo Pharma Ltd.
- Becton, Dickinson And Co.
- Bio-Rad Laboratories Inc.
- Bristol-Myers Squibb Co.
- Cepheid Inc.
- Gilead Sciences Inc.
- Glaxosmithkline Plc
- Hoffmann-La Roche Inc.
- Hologic Inc.
- Janssen Pharmaceuticals Inc.
- Merck & Co. Inc.
- Meridian Life Science Inc.
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
- Viiv Healthcare
For more information about this report visit https://www.researchandmarkets.com/research/cpmmsj/global?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005940/en/